Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Continuous Glucose Monitoring and Global Reimbursement: An Update.

Literature DB >> 28585871

Continuous Glucose Monitoring and Global Reimbursement: An Update.

Abstract

Real-time continuous glucose monitoring has been available for a decade and reimbursement for the technology has been slowly growing. Reasons for the various rates of reimbursement and adoption are explored in this article and the status of country-wide reimbursement is discussed.

Entities: Chemical Disease

Keywords: Continuous glucose monitoring; Cost-effectiveness analysis; Reimbursement

Mesh：

Year: 2017 PMID： 28585871 PMCID： PMC5467100 DOI： 10.1089/dia.2017.0096

Source DB: PubMed Journal: Diabetes Technol Ther ISSN： 1520-9156 Impact factor: 6.118

44 in total

1. Are insulin pumps underutilized in type 1 diabetes? Yes.

Authors: John C Pickup
Journal: Diabetes Care Date: 2006-06 Impact factor: 19.112

2. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.

Authors: Cornelis A J van Beers; J Hans DeVries; Susanne J Kleijer; Mark M Smits; Petronella H Geelhoed-Duijvestijn; Mark H H Kramer; Michaela Diamant; Frank J Snoek; Erik H Serné
Journal: Lancet Diabetes Endocrinol Date: 2016-09-15 Impact factor: 32.069

3. Perceived accuracy in continuous glucose monitoring: understanding the impact on patients.

Authors: William H Polonsky; Danielle Hessler
Journal: J Diabetes Sci Technol Date: 2014-11-10

4. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.

Authors: Roy W Beck; Tonya Riddlesworth; Katrina Ruedy; Andrew Ahmann; Richard Bergenstal; Stacie Haller; Craig Kollman; Davida Kruger; Janet B McGill; William Polonsky; Elena Toschi; Howard Wolpert; David Price
Journal: JAMA Date: 2017-01-24 Impact factor: 56.272

5. Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment.

Authors: O Kordonouri; E Pankowska; B Rami; T Kapellen; R Coutant; R Hartmann; K Lange; M Knip; T Danne
Journal: Diabetologia Date: 2010-08-14 Impact factor: 10.122

Review 6. Comparative analysis of the efficacy of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes mellitus.

Authors: Baraka Floyd; Prakash Chandra; Stephanie Hall; Christopher Phillips; Ernest Alema-Mensah; Gregory Strayhorn; Elizabeth O Ofili; Guillermo E Umpierrez
Journal: J Diabetes Sci Technol Date: 2012-09-01

Review 7. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.

Authors: Rob Riemsma; Isaac Corro Ramos; Richard Birnie; Nasuh Büyükkaramikli; Nigel Armstrong; Steve Ryder; Steven Duffy; Gill Worthy; Maiwenn Al; Johan Severens; Jos Kleijnen
Journal: Health Technol Assess Date: 2016-02 Impact factor: 4.014

8. Continuous glucose monitoring and intensive treatment of type 1 diabetes.

Authors: William V Tamborlane; Roy W Beck; Bruce W Bode; Bruce Buckingham; H Peter Chase; Robert Clemons; Rosanna Fiallo-Scharer; Larry A Fox; Lisa K Gilliam; Irl B Hirsch; Elbert S Huang; Craig Kollman; Aaron J Kowalski; Lori Laffel; Jean M Lawrence; Joyce Lee; Nelly Mauras; Michael O'Grady; Katrina J Ruedy; Michael Tansey; Eva Tsalikian; Stuart Weinzimer; Darrell M Wilson; Howard Wolpert; Tim Wysocki; Dongyuan Xing
Journal: N Engl J Med Date: 2008-09-08 Impact factor: 91.245

9. Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes.

Authors: R Brett McQueen; Samuel L Ellis; Jonathan D Campbell; Kavita V Nair; Patrick W Sullivan
Journal: Cost Eff Resour Alloc Date: 2011-09-14

10. Erratum. Glycemic Targets. Sec. 6. In Standards of Medical Care in Diabetes-2017. Diabetes Care 2017;40(Suppl. 1);S48-S56.

Authors:
Journal: Diabetes Care Date: 2017-05-18 Impact factor: 19.112

15 in total

1. The Future of Continuous Glucose Monitoring.

Authors: Satish K Garg; Halis K Akturk
Journal: Diabetes Technol Ther Date: 2017-06 Impact factor: 6.118

Review 2. Interdisciplinary approach to compensation of hypoglycemia in diabetic patients with chronic heart failure.

Authors: Yana Anfinogenova; Elena V Grakova; Maria Shvedova; Kristina V Kopieva; Alexander T Teplyakov; Sergey V Popov
Journal: Heart Fail Rev Date: 2018-05 Impact factor: 4.214

Review 3. Glycemic Variability: How to Measure and Its Clinical Implication for Type 2 Diabetes.

Authors: Guillermo E Umpierrez; Boris P Kovatchev
Journal: Am J Med Sci Date: 2018-10-02 Impact factor: 2.378

4. Continuous Glucose Monitoring: Current Use in Diabetes Management and Possible Future Applications.

Authors: Martina Vettoretti; Giacomo Cappon; Giada Acciaroli; Andrea Facchinetti; Giovanni Sparacino
Journal: J Diabetes Sci Technol Date: 2018-05-22

Review 5. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.

Authors: David Rodbard
Journal: Diabetes Technol Ther Date: 2017-06 Impact factor: 6.118

6. Designing for engagement with self-monitoring: A user-centered approach with low-income, Latino adults with Type 2 Diabetes.

Authors: Meghan Reading Turchioe; Elizabeth M Heitkemper; Maichou Lor; Marissa Burgermaster; Lena Mamykina
Journal: Int J Med Inform Date: 2019-08-02 Impact factor: 4.046